FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileRockwell Medical, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RMTI
Rockwell Medical, Inc. Stock AnalysisComprehensive stock analysis for Rockwell Medical, Inc. (RMTI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRMTI
RMTI
Rockwell Medical, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RMTI
  1. Home
  2. Stocks
  3. Rockwell Medical, Inc.

Rockwell Medical, Inc.

🇺🇸RMTI•NASDAQ

Rockwell Medical, Inc.

🇺🇸RMTI•NASDAQ
Market cap
$28.33M
Sentiment

Your view on RMTI

Mkt Cap
$28.33M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Rockwell Medical, Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Mark Strobeck
Headquarters
30142 South Wixom road, Wixom, MI, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Mark Strobeck
Headquarters
30142 South Wixom road, Wixom, MI, US
Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally.

The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores.

It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers.

The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream.

It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home.

Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Rockwell Medical, Inc. from FRC's valuation model, read against the market price. RMTI last traded at $7.03; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Rockwell Medical, Inc.. Starting points for Rockwell Medical, Inc.: EPS -$1.42, beta 1.73 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Rockwell Medical, Inc.. Rockwell Medical, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Rockwell Medical, Inc.. Trailing twelve-month EPS for Rockwell Medical, Inc. stands at -$1.42. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 16, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$20.00

average of analysts' targets

 

$20.00

Low $20.00

Median $20.00

High $20.00

 

Analyst Ratings

Buy16 ratings
  • Strong Buy0
  • Buy10
  • Hold2
  • Sell4
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate-$0.43-$0.25-$1.51-$0.73
Low estimate-$0.44-$0.25-$1.53-$0.74
High estimate-$0.42-$0.25-$1.49-$0.72
No. of analysts1111
Year-ago EPS-$0.101-$0.401-$1.501—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$19.00M$18.85M$72.78M$78.62M
Low estimate$18.81M$18.66M$72.09M$77.87M
High estimate$19.20M$19.04M$73.48M$79.37M
No. of analysts1111
Year-ago revenue$18.35M$17.34M$69.26M—
Growth+3.6%+8.7%+5.1%—
Recent analyst actions15 rating and price-target changes, latest Sep 11, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 16, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Rockwell Medical, Inc.. Rockwell Medical, Inc. has reported as a listed company since 1998. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RMTI19 companies · 7 funds
Compare RMTI with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • APUSApimeds Pharmaceuticals US, IncBiotechnology$3M
  • ATHEAlterity Therapeutics LimitedBiotechnology$31M
  • CPIXCumberland Pharmaceuticals Inc.Drug Manufacturers - Specialty & Generic$88M
  • EVAXEvaxion Biotech A/SBiotechnology$17M
  • LIMNLiminatus Pharma, Inc. Class A Common StockBiotechnology$4M
  • NMTCNeuroOne Medical Technologies CorporationMedical - Devices$7M
  • QNTMQuantum BioPharma Ltd.Biotechnology$10M

More Drug Manufacturers - Specialty & Generic companies

  • IPSEYIpsen S.A.OTC$61.0B
  • IRWDIronwood Pharmaceuticals, Inc.NASDAQ$800M
  • ISCNFIsracann Biosciences Inc.OTC$1,982
  • ISOLFIsodiol International Inc.OTC$4,914
  • ITHUFiAnthus Capital Holdings, Inc.OTC$34M
  • IVIXFInvion LimitedOTC$3M
  • IVX.AXInvion LimitedASX
  • JUSH.CNJushi Holdings Inc.CNQ$165M
  • JUVAFJuva Life Inc.OTC$1,641
  • JWCAFJames E. Wagner Cultivation CorporationOTC$10,942
  • KALYKali, Inc.OTC$50,912
  • KAYSKaya Holdings, Inc.OTC

ETFs holding Rockwell Medical, Inc.

% of the fund

  • VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
  • VXFVanguard Extended Market ETF$30.2B in assets0.00%
  • VUN.TOVanguard U.S. Total Market Index ETF$20.1B in assets0.00%
  • VEQT.TOVanguard All-Equity ETF Portfolio$17.6B in assets0.00%
  • VGRO.TOVanguard Growth ETF Portfolio$10.9B in assets0.00%
  • VBAL.TOVanguard Balanced ETF Portfolio$6.0B in assets0.00%
  • VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)$1.4B in assets0.00%

Largest holders first, then the funds most concentrated in RMTI.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Rockwell Medical, Inc., and how their positions are changing. At a $28.3M market value, institutional positions materially move Rockwell Medical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Rockwell Medical, Inc. executives and directors. Shares of Rockwell Medical, Inc. have traded between $0.78 and $2.52 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Rockwell Medical, Inc.. Coverage tracks Rockwell Medical, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Rockwell Medical, Inc.

RMTI Analysis
Weak
Past1
Growth1
Health4
Profit1
Value1

News

Latest Market News